Makary Plans To Review Mifepristone Data, Raising Concerns Of Abortion Pill Access Rollbacks
US FDA Commissioner nominee Martin Makary told Senators that he plans to review the data on the abortion pill mifepristone, raising some lawmakers concerns that older safety requirements the FDA has deemed unnecessary, like in-person dispensing, may be reinstated.
